BridgeBio gains on phase 3 dwarfism data Shares in BridgeBio rose after it revealed data from a trial of infigratinib in achondroplasia, raising the prospect of the first oral treatment.

Shares in #BridgeBio were ticking up today after it revealed data from its phase 3 trial of infigratinib in #achondroplasia, the most common form of #dwarfism, that could form the basis of #regulatory filings.

pharmaphorum.com/news/bridgeb...

BioSpace Unveils the 2026 Best Places to Work in Life Sciences: A Closer Look BioSpace has announced its 2026 Best Places to Work list, celebrating top employers in life sciences, recognizing 50 companies for their exceptional workplace culture.

BioSpace Unveils the 2026 Best Places to Work in Life Sciences: A Closer Look #United_States #BridgeBio #Des_Moines #AbbVie #BioSpace

BridgeBio Pharma Under Investigation: Shareholder Rights at Stake Purcell & Lefkowitz LLP is investigating BridgeBio Pharma Inc. to assess potential breaches of fiduciary duty by its directors. Shareholders are encouraged to get informed.

BridgeBio Pharma Under Investigation: Shareholder Rights at Stake #United_States #New_York #BridgeBio #Shareholder_Rights #Purcell_&_Lefkowitz

NEWS: #Alnylam has the FDA approval it sought for Amvuttra in a form of #cardiomyopathy associated with rare disease #ATTRamyloidosis, allowing it to compete head-to-head with rival therapies from #Pfizer and #BridgeBio.

pharmaphorum.com/news/alnylam...

Original post on medcitynews.com

On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval Bridge...

medcitynews.com/2025/02/on-heels-of-fda-...

#BioPharma #Daily #Legal #Pharma […]

[Original post on medcitynews.com]

Original post on medcitynews.com

On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval Bridge...

medcitynews.com/2025/02/on-heels-of-fda-...

#BioPharma #Daily #Legal #Pharma […]

[Original post on medcitynews.com]

Original post on medcitynews.com

On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval Bridge...

medcitynews.com/2025/02/on-heels-of-fda-...

#BioPharma #Daily #Legal #Pharma […]

[Original post on medcitynews.com]

PANTHERx® Rare Selected to Distribute Attruby™ for TTR Amyloid Cardiomyopathy Treatment PANTHERx® Rare Pharmacy has been chosen by BridgeBio to distribute Attruby™ for treating transthyretin amyloid cardiomyopathy, bringing hope to patients.

PANTHERx® Rare Selected to Distribute Attruby™ for TTR Amyloid Cardiomyopathy Treatment #United_States #Pittsburgh #BridgeBio #Attruby™ #PANTHERx®_Rare

Orsini and BridgeBio Collaboration: New Hope for Cardiomyopathy Patients with ATTRUBY™ Orsini collaborates with BridgeBio to distribute ATTRUBY™, a groundbreaking oral treatment for cardiomyopathy related to transthyretin-mediated amyloidosis, enhancing patient care.

Orsini and BridgeBio Collaboration: New Hope for Cardiomyopathy Patients with ATTRUBY™ #United_States #Orsini_Specialty_Pharmacy #ATTRUBY #BridgeBio #Elk_Grove_Village